Excision BioTherapeutics Inc.

Philadelphia, PA · CIK 0001847173 · Biotech · Private

None identifiable - text describes a music artist/dubstep producer

excisionbio.com →
Grants
$435K
2 awards
Sector median: 1
Raised
$71M
2 Form D · Mar 2021
67 months since last filing
Contracts
—
No federal contracts on record
Patents
40
0 granted · 40 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Towards The Therapeutic Implementation of New CRISPR-Cas Systems$217,484
Federal grantDepartment of Health and Human Services · Phase I · Towards The Therapeutic Implementation of New CRISPR-Cas Systems$217,484
Private capital raisedForm D · SEC$60,738,974
Private capital raisedForm D · SEC$10,500,000
Federal grant · SBIR/STTRForm D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2167Immunovant—$450M
2168Ocugen—$126M
2169VISIONARY PHARMACEUTICALS, INC.——
2170Excision BioTherapeutics Inc.—$71M
2171Context Therapeutics—$100M
2172QT Holdings Corp.—$3.8M
2173LOKI THERAPEUTICS, INC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 4 related persons
  • Vasudev BaileyDirector
  • William CarsonDirector
  • Daniel DornbuschDirector · Executive Officer
  • Ashok KrishnamurthiDirector

Patents

USPTO · 0 granted of 40
  • Guide Nucleic Acid Identification And Methods Of Useapplication
  • Compositions And Methods Of Treatment For Lytic And Lysogenic Virusesapplication
  • Compositions And Methods For Excision With Single Grnaapplication
  • Compositions And Methods Of Treatment For Lytic And Lysogenic Virusesapplication
  • Metabalomics And Viral Diagnostics Suiteapplication
  • Hiv Clinical Planapplication
  • Visualizing Viral Reservoirs And Dissemination In Vivoapplication
  • Lentivirus And Non-integrating Lentivirus As Viral Vector To Deliver Crispr Therapeuticapplication
  • CRISPRsapplication
  • Hepatitis B Virus Guide Nucleic Acid Compositions And Methods Of Useapplication
  • Guide Nucleic Acid Identification And Methods Of Useapplication
  • Hepatitis B Virus Guide Nucleic Acid Compositions And Methods Of Useapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.